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Abstract— The reactivity of Cyproheptadine and Cyclobenzaprine in Pd-catalyzed arylation via C-H bond func-
tionalizations was investigated.  From Cyproheptadine using aryl bromides as aryl sources and 5 mol% of a pal-
ladium catalyst, the C10-arylated Cyproheptadine derivatives were regioselectively obtained.  The highest yields 
were obtained with electron-rich aryl bromides, but the reaction tolerated useful functional groups on the aryl 
bromide such as dimethylamino, methoxy, hydroxyl, alkyl, aryl, fluoro, chloro and trifluoromethyl.  Cycloben-
zaprine was also reactive under the same reaction conditions. © 2019 Elsevier Science. All rights reserved 
 
Keywords: palladium, C-H bond functionalization, Cyproheptadine, Cyclobenzaprine, aryl bromides 
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1. Introduction 
The dibenzo[a,d][7]annulene unit (Fig 1, top) can be found in several drugs.  For example, Cyproheptadine is 
used to treat allergic reactions and cyclical vomiting syndrome; whereas Cyclobenzaprine is employed as 
muscle relaxer medication to relieve skeletal muscle spasms (Fig. 1, bottom).  Moreover, Cyproheptadine might 
be useful for breast cancer treatment [1,2].  Amitriptyline, which can be prepared by reduction of the C10=C11 
double bond of Cyclobenzaprine [3], is one of the most efficient drugs used in the treatment of depression (Fig. 
1, bottom) [4].  Therefore, the development of a methodology employing the so-called late stage C-H bond 
functionalization allowing the easy access in one step to a wide variety of derivatives of these drugs containing 
useful functional groups has potential in pharmaceutical chemistry. 
 
 
Figure 1 Structures of 5H-dibenzo[a,d][7]annulene, Cyproheptadine, Cyclobenzaprine and Amitriptyline 
During the last decades, the metal-catalyzed C–H bond functionalization of a broad range of the sp2 C-H bonds 
[5-14] including cyclic alkenes [15-21]
 
were demonstrated to be extremely effective for the access to sophisti-
cated structures.  With cyclic alkenes, in general the reaction likely proceed via a Heck type mechanism.  How-
ever, as the Heck type -H elimination step is not possible with these substrates – as the hydrogen involved in 
the -hydride elimination process is anti with respect to the Pd-C bond – , a syn ’-hydride elimination may 
occur in some cases [22].  These methodologies are very attractive in terms of late-stage functionalization as it 
does not require the preparation of an organometallic or a boron derivative of one of the coupling partners.  A 
few examples of metal-catalyzed C–H bond functionalization of the C4-position of dibenzo[a,d][7]annulene 
units have been reported [23-26].  For example, in 1996, Dyker described one example of C4-functionalization 
of a 5-methylene-5H-dibenzo[a,d][7]annulene via Pd-catalysis (Scheme 1, a) [23].  In 2017, Yu et al. reported 
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conditions for the intermolecular C4-acylation of 5H-dibenzo[a,d][7]annulen-5-one with 2-oxo-2-phenylacetic 
acid using 5 mol% Pd(OAc)2 catalyst (Scheme 1, b) [24].  In 2016, Nakamura, Ilies et al. methylated the C4-
position of 5H-dibenzo[a,d][7]annulen-5-one with AlMe3 using a Fe-catalyst [25], and very recently, Sundara-
raju et al. described conditions for the Co-catalyzed C4-alkylation of this annulen-5-one with a maleimide [26].   
 
Scheme 1 Pd-catalyzed C-H bond functionalizations of dibenzo[a,d][7]annulene units and of Cyproheptadine 
and Cyclobenzaprine. 
To our knowledge, the Pd-catalyzed C-H bond functionalization of Cyproheptadine and Cyclobenzaprine has 
not yet been described and needed to be investigated.  Herein, we report on the reactivity of Cyproheptadine and 
Cyclobenzaprine in palladium-catalyzed arylations via a C-H bond functionalization using a variety of aryl 
bromides as the aryl source. 
2. Results and discussion 
First, we examined the reactivity of Cyproheptadine in Pd-catalyzed direct arylation in the presence 
KOAc as base using DMA as the solvent (Table 1), as we had previously observed that these reaction 
conditions allowed the coupling of fulvene, acenaphthylene or dibenzo[b,f]azepine derivatives with aryl 
bromides [11,12].  Reactions performed with 5 mol% Pd(OAc)2 or PdCl2(MeCN)2 as the catalysts at 
150 °C during 16 or 48 h using 4-bromotoluene as the aryl source regioselectively afforded the C10-
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arylated Cyproheptadine 1 in 17-27% yields (Table 1, entries 1- 3).  No arylations at other positions of 
Cyproheptadine were observed by GC/MS analysis of the crude mixtures.  Then, the influence of a set 
of phosphine ligands on the reaction was examined.  Higher yields in 1 were obtained with PPh3 and 
dppb than with the electron-rich PCy3 ligand (Table 1, entries 4-7).  The use of PdCl(C3H5)(dppb) [27] 
as the catalyst afforded 1 in a higher yield of 41% (Table 1, entry 8).  Other bases (K2CO3, Cs2CO3, 
CsOAc, NaOAc or DBU) and other solvents (DMF, NMP and xylene), afforded 1 in lower yields (Ta-
ble 1, entries 9-16).  Using a shorter reaction time (16 h instead of 48 h), 1 was obtained in a similar 
yield; whereas after 4 h the yield in 1 dropped to 34% due to a partial conversion of 4-bromotoluene 
(Table 1, entries 17 and 18).  The use of 4-iodotoluene instead of 4-bromotoluene with 
PdCl(C3H5)(dppb) catalyst afforded 1 in only 11% yield, and the formation of a large amount of 4,4'-
dimethyl-1,1'-biphenyl due to the homo-coupling of 4-iodotoluene was observed (Table 1, entry 19).  
On the other hand, with 4-chlorotoluene as aryl source, product 1 was obtained in 19% due to a poor 
conversion of this aryl chloride (Table 1, entry 20). 
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Table 1.  Influence of the reaction conditions on the coupling of Cyproheptadine with 4-bromotoluene 
 
Entry Catalyst (mol%) Solvent Base Yield (%) 
1 Pd(OAc)2 DMA KOAc 24 
2 Pd(OAc)2 DMA KOAc 17
a
 
3 PdCl2(MeCN)2 DMA KOAc 27 
4 Pd(OAc)2 / 2 PPh3 DMA KOAc 20
a
 
5 Pd(OAc)2 / 2 PCy3 DMA KOAc 6
a
 
6 Pd(OAc)2 / dppe DMA KOAc 14
a
 
7 Pd(OAc)2 / dppb DMA KOAc 24
a
 
8 PdCl(C3H5)(dppb) DMA KOAc 41 
9 PdCl(C3H5)(dppb) DMA K2CO3 0 
10 PdCl(C3H5)(dppb) DMA Cs2CO3 0 
11 PdCl(C3H5)(dppb) DMA CsOAc 5 
12 PdCl(C3H5)(dppb) DMA NaOAc 8 
13 PdCl(C3H5)(dppb) DMA DBU 5
a
 
14 PdCl(C3H5)(dppb) DMF KOAc 0 
15 PdCl(C3H5)(dppb) NMP KOAc 5 
16 PdCl(C3H5)(dppb) xylene KOAc 0 
17 PdCl(C3H5)(dppb) DMA KOAc 39
a
 
18 PdCl(C3H5)(dppb) DMA KOAc 34
b
 
19 PdCl(C3H5)(dppb) DMA KOAc 11
a,c
 
20 PdCl(C3H5)(dppb) DMA KOAc 19
a,d
 
Conditions: Catalyst (0.05 equiv.), Cyproheptadine (1 equiv.), 4-bromotoluene (2 equiv.), base (3 equiv.), 48 h, 
150 °C, isolated yields of 1. 
a
 16 h. 
b
 4 h. 
c
 From 4-iodotoluene. 
d
 From 4-chlorotoluene. 
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Then, the scope of the coupling of Cyproheptadine with a set of aryl bromides in the presence of 5 
mol% PdCl(C3H5)(dppb), KOAc as the base in DMA at 150 °C was investigated (Scheme 2).  No for-
mation of the desired product 2 was detected with the highly electron-deficient 4-bromobenzonitrile.  
Conversely, low yields in the target products 3-5 were obtained for the reactions with the less electron-
deficient 4-bromobenzotrifluoride, 4-bromochlorobenzene and 4-bromofluorobenzene, although com-
plete conversions of these aryl bromides were observed.  With these three aryl bromides, the formation 
of large amounts of aryl bromide homo-coupling products and unidentified degradation products was 
observed by NMR analysis of the crude mixtures.  Higher yields were obtained for the reactions with 
electron-neutral or -rich aryl bromides.  From bromobenzene, the C10-phenyl substituted Cyprohepta-
dine 6 was obtained in 51% yield.  Aryl bromides bearing tert-butyl, phenyl or methoxy para-
substituents afforded the target products 7-9 in 45-72% yields.  Even 4-bromo-N,N-dimethylaniline was 
reactive providing the product 10 in 38% yield.  The structure of 10 was confirmed by X-ray analysis.  
From a 4-bromobiphenyl bearing a free OH group, the desired product 11 was obtained in moderate 
yield.  Interestingly, the OH group remained untouched allowing further transformations.  The low reac-
tivity of electron-poor aryl halides compared to electron-rich aryl halides had already been observed for 
related Pd catalyzed reactions [28]. 
The reactivity of four meta-substituted aryl bromides was also examined.  Again, the “quite strong” 
electron-withdrawing substituent CF3 on the aryl bromide led to the coupling product 12 a in lower 
yield than the chloro-, methyl- and methoxy-substituted aryl bromides which afforded the products 13-
15 in 41-63% yields.  Unprotected 6-bromo-2-naphthol and the more hindered 2-bromotoluene, 1-
bromonaphthalene and 1-bromo-4-fluoronaphthalene were also found to be useful substrates for this 
reaction, as the products 16-19 were obtained in 34-55% yields.  Finally, the dimethoxy-substituted aryl 
bromide, 4-bromoveratrole provided the C10-arylated Cyproheptadine derivative 20 in 34% yield. 
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Scheme 2 Palladium-catalyzed C10-arylations of Cyproheptadine. 
By contrast, the direct arylation of Cyclobenzaprine with 1-bromo-4-tert-butylbenzene produced an 
equimolar mixture of the two regioisomeric compounds 21a and 21b in 42% yield (Scheme 3).   
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Scheme 3 Palladium-catalyzed direct arylations of Cyclobenzaprine. 
These two regioisomers were separated by silica gel column chromatography, and the structures of 21a 
and 21b were assigned by NMR analysis. Relevant spatial proximities (determined by NOESY experi-
ments) are shown in figure 2 (see supporting information for more details). Structure of 21a is supposed 
to be twisted since a correlation is seen between protons from the aryl of tBu-aryl group and N-methyl.  
It can be seen from the X-ray solid structure of 10 that the NMe2-aryl group and the methyl-piperidine 
moiety are located on the same side of the tricyclic part.  For 21a, methyl-piperidine is replaced by a 
N,N-dimethylethanamine unit which is likely to be much more flexible.  
 
Figure 2 Relevant NOESY correlations observed for compounds 21a and 21b 
In summary, we report here the first method allowing to prepare C10-arylated Cyproheptadine derivatives.  As 
this method employs the so-called late-stage C-H bond functionalization methodology, no preparation of specif-
ic starting materials is required allowing an easy tuning of the steric and electronic properties of the introduced 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
aryl group.  Moreover, these arylation were performed using the air-stable PdCl(C3H5)(dppb) catalyst precursor 
associated to KOAc as inexpensive base, and tolerated useful functional groups on the aryl bromide such as di-
methylamino, methoxy, hydroxyl, alkyl, aryl, fluoro, chloro and trifluoromethyl.  We also describe the catalytic 
C10/C11-arylation of Cyclobenzaprine.  In the course of this reaction an equimolar mixture of the two regioi-
somers which could be separated by column chromatography was formed.  Such late-stage functionalizations of 
important drugs should allow a fast screening of the influence of aryl groups at C10-position on their biological 
properties.  This work should also lead to the development of new synthetic pathways by functionalizing the 
C10/C11 positions of these drugs through the use of different coupling partners. 
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*Highlights  
 First regioselective arylations at the C10-position of Cyproheptadine 
 One step access to Cyproheptadine congeners 
 Good functional group tolerance 
 Air and moisture tolerant Pd-catalyst 
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